Français
ItalianoBond AdvanzPharm 9.5% ( USC26215AB61 ) in USD
| Issuer | AdvanzPharm |
| Market price | 100 % ▲ |
| Country |  Canada
|
| ISIN code |
 USC26215AB61 ( in USD )
|
| Interest rate | 9.5% per year ( payment 2 times a year) |
| Maturity | 21/10/2022 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 790 000 000 USD |
| Cusip | C26215AB6 |
| Standard & Poor's ( S&P ) rating | N/A |
| Moody's rating | N/A |
| Detailed description |
Advanz Pharma is a pharmaceutical company focused on developing and commercializing branded and generic prescription drugs, primarily in the areas of gastroenterology, pain management, and central nervous system disorders. The Canadian-issued bond from Advanz Pharma, a global specialty pharmaceutical company dedicated to providing innovative and established medicines, identified by ISIN USC26215AB61 and CUSIP C26215AB6, which had an impressive total issuance size of $790,000,000 and required a minimum investment of $2,000, featured a 9.5% annual coupon rate paid semi-annually in USD and, having been last observed trading at 100% of its par value, successfully reached its maturity on October 21, 2022, and has since been fully repaid to its investors. |